1. Home
  2. APGE vs PFS Comparison

APGE vs PFS Comparison

Compare APGE & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • PFS
  • Stock Information
  • Founded
  • APGE 2022
  • PFS 1839
  • Country
  • APGE United States
  • PFS United States
  • Employees
  • APGE N/A
  • PFS N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • PFS Savings Institutions
  • Sector
  • APGE Health Care
  • PFS Finance
  • Exchange
  • APGE Nasdaq
  • PFS Nasdaq
  • Market Cap
  • APGE 3.0B
  • PFS 2.8B
  • IPO Year
  • APGE 2023
  • PFS N/A
  • Fundamental
  • Price
  • APGE $48.46
  • PFS $20.30
  • Analyst Decision
  • APGE Strong Buy
  • PFS Strong Buy
  • Analyst Count
  • APGE 6
  • PFS 5
  • Target Price
  • APGE $75.40
  • PFS $22.60
  • AVG Volume (30 Days)
  • APGE 588.6K
  • PFS 497.9K
  • Earning Date
  • APGE 11-12-2024
  • PFS 01-23-2025
  • Dividend Yield
  • APGE N/A
  • PFS 4.71%
  • EPS Growth
  • APGE N/A
  • PFS N/A
  • EPS
  • APGE N/A
  • PFS 0.98
  • Revenue
  • APGE N/A
  • PFS $526,013,000.00
  • Revenue This Year
  • APGE N/A
  • PFS N/A
  • Revenue Next Year
  • APGE N/A
  • PFS $27.36
  • P/E Ratio
  • APGE N/A
  • PFS $20.59
  • Revenue Growth
  • APGE N/A
  • PFS 13.26
  • 52 Week Low
  • APGE $22.20
  • PFS $13.07
  • 52 Week High
  • APGE $72.29
  • PFS $22.24
  • Technical
  • Relative Strength Index (RSI)
  • APGE 47.85
  • PFS 46.40
  • Support Level
  • APGE $41.85
  • PFS $20.09
  • Resistance Level
  • APGE $48.27
  • PFS $20.78
  • Average True Range (ATR)
  • APGE 3.56
  • PFS 0.45
  • MACD
  • APGE 0.31
  • PFS -0.13
  • Stochastic Oscillator
  • APGE 47.51
  • PFS 13.87

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

Share on Social Networks: